Updates on Human-Relevant Methods in Pharmaceutical Medicine and the Legislative Process

On December 1, 2022, the Center for Contemporary Sciences (CCS) hosted its second Discovery Forum. The event was an opportunity to discuss the updates on human-relevant methods that can replace animal testing and the FDA Modernization Act 2.0. Speakers across industry and academia met to give their takeaways on how to improve the drug development […]

CCS Publication in Frontiers in Medical Technology

In a key study published on December 6, 2022, in Nature Communications Medicine, Ewart et al. introduced a paradigm-shifting solution to the inefficient drug discovery process (1). It entails the incorporation of Liver-Chip platforms as refinement tools within the preclinical assessment and lead optimization stages. This work first appeared in bioRxiv and is now entitled “Performance assessment and […]

Analyzing the Policy Framework of Human-Relevant, Transformative Scientific Innovations

On June 23, 2022, the Center for Contemporary Sciences (CCS) hosted its inaugural Discovery Forum. The event was an opportunity to analyze the policy framework underlying the most transformative scientific innovations of the decade. Emphasis was placed on new inventions enabled by advances in regenerative medicine, biomedical engineering, machine learning, and nanotechnology. This included applications […]

‘The End of Medicine’ Action Plan

Moved by ‘The End of Medicine’ Film Discussion to act? Here are some steps you can take that will help prevent the next pandemic, reduce the human health impact from animal agriculture, and support animal protection. View File  

Animals in Laboratories Speak

Every year, more than 100 million animals are used in experimentation in the U.S. The Animal Welfare Act (AWA) is the only U.S. federal statute that regulates the treatment of animals used in experiments. However, it excludes >95% of animals used. Additionally, even for the species which are covered, the AWA provides no limits on […]

CCS Investor Summit 2022 Report

On March 24, 2022, CCS hosted its first ever Investor Summit in partnership with Beyond Animal. The Summit was open to the public and brought together an international group of innovators, investors, researchers, start-ups, and venture philanthropists. The packed, three-hour-Summit was an opportunity to provide needed exposure to business entities in the space, promote the […]

The Future of Parkinson’s Disease Research

Check out CCS’s latest scientific publication on Parkinson’s Disease research. In coordination with the Center for Alternatives to Animal Testing (CAAT), CCS held a workshop May 2021 to develop a scheme that outlines the basic research and testing approaches necessary to make PD research a success—elucidating pathological mechanisms, identifying knowledge gaps, discovering druggable targets, and developing […]